ArticleFrontiers in cardiovascular medicine2026
Highly suspected fulminant myocarditis induced by the immune checkpoint inhibitor tislelizumab: a case report with third-degree atrioventricular block and recurrent ventricular tachycardia.
Junru Qu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.